Diagnostic Value of Anti-Mutated Citrullinated Vimentin versus Anti-Keratin Anti-Bodies in Early Diagnosis of Rheumatoid Arthritis

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view

“…Anti-MCV chiefly associates with higher levels of the disease activity score (DAS28) (40) and joint damages. This accelerates early diagnosis, reliable progression follow up, assessment of functional disability, and response to drug therapy (27,(41)(42)(43)(44)(45). In some studies, it is demonstrated that anti-MCV antibodies may be precious factor for RA diagnose in anti-CCP-negative patients.…”